A study of BB-001 in patients with B-cell lymphoma

Trial Profile

A study of BB-001 in patients with B-cell lymphoma

Phase of Trial: Phase I

Latest Information Update: 07 Jul 2016

At a glance

  • Drugs BB 001 (Primary)
  • Indications B cell lymphoma
  • Focus Adverse reactions
  • Most Recent Events

    • 07 Jul 2016 New trial record
    • 12 Sep 2013 According to a Bullet Biotechnology media release, the company is planning to start this study in the year 2015.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top